The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 28, 1994

Filed:

Jul. 15, 1992
Applicant:
Inventors:

Mathew Carson, Nutley, NJ (US);

Ru-Jen L Han, Princeton Junction, NJ (US);

Ronald A LeMahieu, N. Caldwell, NJ (US);

Vincent S Madison, Mountain Lakes, NJ (US);

Assignee:

Hoffmann-La Roche Inc., Nutley, NJ (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K / ; C07C / ; C07C / ; C07D / ;
U.S. Cl.
CPC ...
514533 ; 514120 ; 514121 ; 514311 ; 514357 ; 514510 ; 514538 ; 514539 ; 514562 ; 514566 ; 514569 ; 546172 ; 546174 ; 546335 ; 558 70 ; 560 12 ; 560 22 ; 560 40 ; 560 41 ; 560 43 ; 560 44 ; 560 45 ; 562426 ; 562430 ; 562433 ; 562443 ; 562444 ; 562448 ; 562452 ; 562453 ; 562456 ; 562457 ;
Abstract

Compounds of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, n, m, o, p and q are as hereinafter set forth, and, when R.sub.2 is hydrogen, pharmaceutically acceptable salts thereof with bases, are described. The compounds of formula 1 are potent inhibitors of phospholipases A.sub.2 (PLA.sub.2 's) and are therefore useful in the treatment of inflammatory diseases, such as psosiasis, inflammatory bowel disease, asthma, allergy, arthritis, dermatitis, gout, pulmonary disease, myocardial ischemia/reperfusion, and trauma induced inflammation, such as spinal cord injury.


Find Patent Forward Citations

Loading…